Skip to content

Morton Toe and Neuromuscular Performance

Morton Toe is Associated With Faster Contractile Properties and Superior Reactive Strength in Female Football Players

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07588048
Enrollment
47
Registered
2026-05-14
Start date
2026-01-10
Completion date
2026-03-15
Last updated
2026-05-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Foot Morphology, Morton Toe, Neuromuscular Properties

Keywords

Morton toe, tensiomyography, reactive strength index, drop jump, foot morphology, female football, neuromuscular performance

Brief summary

This cross-sectional observational study investigated whether female football players with Morton toe morphology differ from those with normal foot morphology in neuromuscular contractile properties and kinetic performance characteristics. Morton toe is a congenital foot variation in which the second toe is longer than the first. A total of 47 female football players were classified into two groups based on bilateral foot morphology: Morton foot group (n = 24) and normal foot group (n = 23). Neuromuscular properties of the dominant vastus lateralis muscle were assessed using tensiomyography, and kinetic performance was evaluated through a 40-cm drop jump test on dual force plates. The primary outcomes were contraction time (Tc) and reactive strength index (RSI). Secondary outcomes included relaxation time, delay time, sustain time, maximal displacement, jump height, peak power normalized to body mass, and landing net peak force normalized to body mass. Multiple linear regression models adjusted for age, body mass index, and mean arch index were used to evaluate whether group differences were independent of potential confounders. This study aimed to determine whether Morton toe morphology is associated with distinct neuromuscular and kinetic performance profiles in female athletes.

Detailed description

Morton toe is a congenital foot morphology characterized by a longer second metatarsal relative to the first. Although traditionally regarded as a clinical or orthopedic variation associated with metatarsal stress fractures and balance difficulties, limited evidence from sprinter populations suggests that a longer second toe may be associated with superior athletic performance. However, no previous study has examined whether Morton toe morphology is related to neuromuscular contractile properties assessed via tensiomyography or kinetic performance derived from force plate testing in a controlled group comparison design. Participants were screened from 97 female football players. Exclusion criteria included BMI outside the 18.5-29.9 range, bilateral arch index outside the 14-29% range, inconsistent bilateral foot morphology, lower-extremity injury within the past 12 months, neurological or orthopedic conditions, performance-affecting pharmacological use, and menstruation on the measurement day. Morton toe classification was based on the palpation method described by Davidson et al. (2007) with a minimal detectable change threshold of ±0.30 mm. All measurements were conducted during the off-season to minimize training load interference. Testing followed a standardized sequence: foot morphology assessment, tensiomyography of the dominant vastus lateralis at rest, a 15-minute warm-up, and a 40-cm drop jump test. The assessor was blinded to group classification, and statistical analysis was performed by an independent researcher on a coded dataset. Primary outcome variables (Tc and RSI) were determined a priori. Secondary outcomes were corrected for multiple comparisons using the Holm-Bonferroni method. Regression analyses were performed to assess the independence of group effects from age, body mass index, and mean bilateral arch index.

Interventions

None listed

Sponsors

Giresun University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Active female football players with a valid sports license for the current season * Regular participation in training and competitive matches * Bilateral Morton toe morphology (Δ ≤ -0.30 mm on both feet) or bilateral normal foot morphology (Δ \> +0.30 mm on both feet) * Body mass index between 18.5 and 29.9 kg/m² * Bilateral arch index between 14% and 29% * Voluntary participation with written informed consent

Exclusion criteria

* Serious lower-extremity musculoskeletal injury within the past 12 months * Neurological or orthopedic disease affecting measurement procedures * Current use of pharmacological products affecting performance * Acute pain, injury, or illness on the measurement day * Menstruation on the measurement day (self-reported) * Inconsistent bilateral foot morphology classification between feet * Bilateral arch index below 14% (high arch) or above 29% (low arch)

Design outcomes

Primary

MeasureTime frameDescription
Contraction Time (Tc)Single measurement sessionTensiomyographic contraction time of the dominant vastus lateralis muscle, defined as the time between 10% and 90% of maximal radial displacement (ms).
Reactive Strength Index (RSI)Single measurement sessionJump height divided by ground contact time during a 40-cm drop jump test (m/s). The trial with the highest RSI value out of three attempts was selected for analysis.

Secondary

MeasureTime frameDescription
Maximal Displacement (Dm)Single measurement sessionPeak radial displacement of the vastus lateralis muscle belly during tensiomyographic measurement (mm).
Relaxation Time (Tr)Single measurement sessionTime from 90% to 50% of maximal displacement during the relaxation phase of tensiomyographic measurement (ms).
Delay Time (Td)Single measurement sessionTime from electrical stimulus onset to 10% of maximal displacement during tensiomyographic measurement (ms).
Sustain Time (Ts)Single measurement sessionDuration the muscle response remains above 50% of maximal displacement during tensiomyographic measurement (ms).
Jump Height (JH)Single measurement sessionVertical jump height calculated from flight time during a 40-cm drop jump test (cm).
Peak Power Normalized to Body Mass (PPI)Single measurement sessionPeak power output normalized to body mass during a 40-cm drop jump test (W/kg).
Landing Net Peak Force Normalized to Body Mass (LPF)Single measurement sessionPeak vertical ground reaction force at landing normalized to body mass during a 40-cm drop jump test (N/kg).

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 15, 2026